FRA/TN8 (FRA/TN8)

Frankfurt Stock Exchange: FRA/TN8 · EUR

€623

+14.42 (+2.4%)· Recorded snapshot

Market cap	230B
Revenue (ttm)	41.6B
Net income (ttm)	6.2B
EPS (ttm)	€17.0
P/E (trailing)	36.6x
P/E (forward)	25.7x
Dividend	€1.59 (0.25%)
Volume	125

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 41.6B
Net income (ttm): 6.2B
EPS (ttm): €17.0
P/E (trailing): 36.6x
P/E (forward): 25.7x
Market cap: 230B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.7

P25 n/aP50 n/aP75 n/a

Trailing P/E36.6

P25 n/aP50 n/aP75 n/a

ROE13.4

P25 n/aP50 n/aP75 n/a

ROIC9.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/TN8 indicators

Market & fundamental data

Available fields

257

Groups with data

Currency

USD

Showing 257 of 257 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-21
Employees	125,000
Employees change	3,000
Employees growth	2.46%
Enterprise value	EUR 261.8B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-09-26
First seen	2026-05-10
Fiscal year end	December
Founded	1956
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	US8835561023
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Market cap	EUR 230B
Price	EUR 622.80
Price currency	EUR
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-27
Symbol	fra/TN8
Website	https://www.thermofisher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	31.57x
Average P/E ratio (3Y)	31.2x
Average P/E ratio (5Y)	31.63x
Earnings yield	2.73%
EV/Earnings	42.18x
EV/EBIT	32.31x
EV/EBITDA	23.09x
EV/FCF	39.27x
EV/Sales	6.16x
FCF / EV yield	2.55%
FCF yield	2.9%
Forward P/E	25.74x
Graham number	222.09526
Graham upside	-64.34%
Lynch fair value	EUR 84.03
Lynch upside	-86.51%
P/(FCF - SBC) ratio	35.97x
P/(OCF - SBC) ratio	29.08x
P/B ratio	4.77x
P/E ratio	36.57x
P/FCF ratio	34.5x
P/OCF ratio	28.11x
P/S ratio	5.53x
Price/EBITDA ratio	21.49x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.2%
EBITDA margin	25.76%
Effective tax rate	9.48%
FCF margin	15.68%
Gross margin	41.18%
Operating margin	19.2%
Pretax margin	16.55%
Profit margin	14.94%
Profit per employee	EUR 49,645
Profitable quarters	98
Profitable years	24
Revenue per employee	EUR 332,404
ROA	5.23%
ROA (5Y)	5.62%
ROCE	9.09%
ROE	13.38%
ROE (5Y)	15.21%
ROIC	9.07%
ROIC (5Y)	10.84%
SBC / revenue	0.65%
Tax / revenue	1.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.54%
EPS growth (Q)	8.67%
EPS growth (QoQ)	-0.84%
EPS growth 10Y	14.26%
EPS growth 3Y	7.53%
EPS growth 5Y	-2.52%
EPS growth quarters	7
EPS growth years	2
FCF growth	24.3%
FCF growth (Q)	15.15%
FCF growth (QoQ)	26.15%
FCF growth 3Y	5.08%
FCF growth 5Y	-0.82%
Gross profit growth	7.71%
Gross profit growth (Q)	13.24%
Gross profit growth 3Y	3.89%
Gross profit growth 5Y	-0.46%
Net income growth	7.64%
Net income growth (Q)	6.5%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	5.98%
Net income growth 5Y	-3.76%
Net income growth quarters	3
Net income growth years	2
OCF growth	21.87%
OCF growth (Q)	13.89%
OCF growth (QoQ)	20%
OCF growth 10Y	11.01%
OCF growth 3Y	4.5%
OCF growth 5Y	-1.77%
Operating income growth	11.07%
Operating income growth (Q)	14.32%
Operating income growth 3Y	6.53%
Operating income growth 5Y	-3.21%
Revenue growth	8.27%
Revenue growth (Q)	9.13%
Revenue growth (QoQ)	1.19%
Revenue growth 10Y	10.17%
Revenue growth 3Y	2.93%
Revenue growth 5Y	3.93%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.5B
Depreciation and amortization	EUR 2.8B
EBIT	EUR 8B
EBITDA	EUR 10.7B
EPS	EUR 17.03
Financing cash flow	EUR 1.7B
Free cash flow	EUR 6.7B
Free cash flow minus SBC	EUR 6.4B
Gross profit	EUR 17.1B
Income taxes	EUR 652M
Investing cash flow	EUR -7B
Net borrowing	EUR 5.7B
Net cash flow	EUR 3.1B
Net income	EUR 6.2B
Operating cash flow minus SBC	EUR 7.9B
Operating income	EUR 8B
Revenue	EUR 41.6B
Stock-based compensation	EUR 272M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 129.89
Debt / EBITDA	3.26
Debt / equity	0.75
Debt / FCF	5.45
Goodwill	EUR 48.7B
Interest coverage	5.92
Long-term assets	EUR 77.2B
Long-term liabilities	EUR 39.3B
Net cash (debt)	EUR -31B
Net cash / market cap	-13.47%
Net debt / EBITDA	2.89
Net debt / equity	0.64
Net debt / FCF	4.65
Piotroski F-Score	6
Property, plant and equipment	EUR 9.5B
Shareholders' equity	EUR 48.2B
Tangible book value	EUR -15.4B
Tangible book value per share	EUR -41.68
Total assets	EUR 100.2B
Total cash	EUR 5.3B
Total debt	EUR 36.3B
Total liabilities	EUR 52.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	EUR 23B
Current liabilities	EUR 12.7B
Current ratio	1.81
Inventory turnover	4.89
Net working capital	EUR 6.7B
Quick ratio	1.11
Working capital	EUR 10B
Working capital turnover	4.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.52%
Dividend growth	5.39%
Dividend growth (10Y)	11.43%
Dividend growth (3Y)	8.06%
Dividend growth (5Y)	13.72%
Dividend growth years	8
Dividend payment date	2026-10-15
Dividend payment years	15
Dividend payout frequency	Quarterly
Dividend per share	EUR 1.59
Dividend yield	0.25%
Ex-dividend date	2026-09-15
Last dividend	EUR 0.41
Payout ratio	9.52%
Shareholder yield	1.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	364.77%
10Y return CAGR	16.94%
10Y total return	378.12%
150-day SMA	EUR 481.23
15Y price change	1,705.74%
15Y return CAGR	21.74%
15Y total return	1,811.93%
1D price change	2.37%
1M price change	5.38%
1M total return	5.38%
1W price change	1.7%
1W total return	1.7%
1Y price change	26.29%
1Y return CAGR	26.75%
1Y total return	26.73%
20-day SMA	EUR 600.23
200-day SMA	EUR 474.56
20Y price change	1,739.34%
20Y return CAGR	16%
20Y total return	1,847.51%
3M price change	26.95%
3M total return	27.04%
3Y price change	47.79%
3Y return CAGR	14.27%
3Y total return	49.23%
50-day SMA	EUR 568.56
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 623.40
52-week high date	2026-10-16
52-week low	EUR 374.80
52-week low date	2026-05-18
5Y price change	18.67%
5Y return CAGR	3.78%
5Y total return	20.38%
6M price change	55.39%
6M total return	55.66%
All-time high	EUR 623.40
All-time high date	2026-10-16
All-time low	EUR 11.80
All-time low date	1999-10-15
Average true range (ATR)	EUR 11.73
Average volume	104.7
Change from 52-week high	-0.1%
Change from 52-week low	66.17%
Change from all-time high	-0.1%
Change from all-time low	5,177.97%
Change from open	1.9%
Day's gap	0.46%
Dollar volume	EUR 77,850
High price	EUR 622.80
Low price	EUR 610.40
Monthly RSI	66.09
Open price	EUR 611.20
Position in 52-week range	100%
Previous close	EUR 608.40
Price vs 150-day SMA	29.42%
Price vs 20-day SMA	3.76%
Price vs 200-day SMA	31.24%
Price vs 50-day SMA	9.54%
Relative volume	1.19
RSI	63.73
Sharpe ratio	0.85
Sharpe ratio (3Y)	0.46
Sharpe ratio (5Y)	0.08
Sortino ratio	1.47
Sortino ratio (3Y)	0.92
Sortino ratio (5Y)	0.32
Volume	125
Weekly RSI	73.44
YTD price change	25.44%
YTD total return	25.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	368.8M
Shares change (QoQ)	0%
Shares change (YoY)	-1.52%
Shares held by insiders	0.12%
Shares held by institutions	92.52%
Short ratio	2.3 days

Deeper analysis on FRA/TN8

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/TN8 report

Is a complete FRA/TN8 research report available?

No complete published report is available for fra/TN8 (FRA/TN8) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/TN8 (FRA/TN8)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/TN8

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/TN8 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/TN8

Frequently asked questions